Regenxbio (RGNX) Other Working Capital Changes (2014 - 2025)

Regenxbio's Other Working Capital Changes history runs 12 years deep, the most recent figure standing at -$4.5 million for Q4 2025.

• In Q4 2025, Other Working Capital Changes fell 134.32% year-over-year to -$4.5 million; the TTM figure through Dec 2025 stood at -$658000.0 (up 87.93% YoY), while the FY2025 annual figure was -$658000.0, up 87.93% from the prior year.
• Other Working Capital Changes was -$4.5 million for Q4 2025 at Regenxbio, down from $2.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $39.8 million in Q1 2025 to a low of -$38.1 million in Q2 2025.
• Historically, Other Working Capital Changes has averaged -$668700.0 across 5 years, with a median of -$697500.0 in 2021.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 972.02% in 2022, then slumped 1018.5% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$4.2 million in 2021, then slumped by 82.5% to -$7.7 million in 2022, then soared by 97.75% to -$173000.0 in 2023, then plunged by 1018.5% to -$1.9 million in 2024, then plunged by 134.32% to -$4.5 million in 2025.
• The last three Other Working Capital Changes figures came in at -$4.5 million (Q4 2025), $2.2 million (Q3 2025), and -$38.1 million (Q2 2025), per Business Quant data.